Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;17 Suppl 1(Suppl 1):S1-S7.
doi: 10.1002/jhm.12918.

Missed diagnosis of cirrhosis in the inpatient setting

Affiliations
Review

Missed diagnosis of cirrhosis in the inpatient setting

Alpesh N Amin et al. J Hosp Med. 2022 Aug.

Abstract

Cirrhosis accounts for a large number of deaths in the United States and worldwide, leading to an increasing burden on the healthcare system. Cirrhosis is, however, a progressive disease with different potential complications related to liver dysfunction and portal hypertension. Often, patients may present with complications of cirrhosis without having been diagnosed previously. It is pertinent that clinicians recognize these signs to place patients on an appropriate course of management to help delay or avoid further disease progression while avoiding deleterious outcomes and unnecessary utilization. We will discuss the epidemiology of liver disease, cirrhosis, and its complications (hepatic encephalopathy, ascites, and varices). In this study, we will discuss the rationale and impact of missing these diagnoses on the healthcare system and patient.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

Alpesh Amin reported serving as PI or co-I of clinical trials sponsored by NIH/NIAID, NeuroRx Pharma, Pulmotect, Blade Therapeutics, Novartis, Takeda, Humanigen, Eli Lilly, PTC Therapeutics, OctaPharma, Fulcrum Therapeutics, Alexion, unrelated to the present study; speaker and/or consultant for BMS, Pfizer, BI, Portola, Sunovion, Mylan, Salix, Alexion, AstraZeneca, Novartis, Nabriva, Paratek, Bayer, Tetraphase, Achogen, LaJolla, Ferring, Seres, Spero, Eli Lilly, Millenium, PeraHealth, HeartRite, Aseptiscope, Sprightly, unrelated to the present study.

Elliot Tapper has served as a consultant to Norvartis, Axcella, and Allergan, has served on advisory boards for Mallinckrodt, Bausch Health, Kaleido, Novo Nordisk, and has received unrestricted research grants from Gilead and Valeant.

Peter Nguyen has no conflict of interest

Figures

Figure 1
Figure 1
Noninvasive assessment of cirrhosis Three of the major ways that cirrhosis can be detected noninvasively are using radiological signs of portal hypertension, indirect serological signs, and liver elastography. AST = Aspartate Aminotransferase, ALT = Alanine Aminotransferase

References

    1. Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666. doi:10.1016/j.cgh.2019.07.060 - DOI - PMC - PubMed
    1. Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open. 2020;3(4):e201997. Published 2020 Apr 1. doi:10.1001/jamanetworkopen.2020.1997 - DOI - PMC - PubMed
    1. Peery AF, Crockett SD, Murphy CC, et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology. 2022;162(2):621–644. doi:10.1053/j.gastro.2021.10.017 - DOI - PMC - PubMed
    1. Tapper EB, Halbert B, Mellinger J. Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. Clin Gastroenterol Hepatol. 2016;14(8):1181–1188.e2. doi:10.1016/j.cgh.2016.04.009 - DOI - PubMed
    1. De Bruyn G, Graviss EA. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC medical informatics and decision making 2001;1:6. - PMC - PubMed

Publication types

MeSH terms